Hyperfine MRI to Detect Brain Injury in Children on ECMO
ECMO ABI Detection With Hyperfine
- Age
- 0 Days – 17
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 40 (estimated)
- Sponsor
- Children's Mercy Hospital Kansas City · Other
This trial is looking for young patients aged 0-17 who are receiving specialized life support called ECMO. Participants will undergo a special type of MRI to help understand brain injuries related to their treatment.
You may be able to join if
- I am aged 0-17 years
- I am receiving care in a Pediatric or Neonatal Intensive Care Unit
- I am at high risk for needing ECMO or am currently on ECMO
- I am undergoing cardiac surgery
- I have congenital heart disease
- I have a congenital diaphragmatic hernia
- I am experiencing severe respiratory failure
- I have vasoactive-refractory shock
You may not be able to join if
- I am pregnant
- I cannot have an MRI for medical reasons
- I have a medical device that is not safe for MRI
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityThe primary objective is to characterize the prevalence and type of ABI following cannulation for pediatric patients who require ECMO support. The secondary objective is to describe the time course and rates of ABI using ultralow-field bedside MRI relative to both duration of ECMO support and clinical imaging obtained in routine care of pediatric ECMO patients.
Loading trial locations…